☆ 4.3 Article

Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?

NEONATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pediatrics

Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates

Samira Samiee-Zafarghandy et al.

Summary: This study explores the pharmacokinetics of ibuprofen in neonates for the closure of patent ductus arteriosus, finding a strong correlation between ibuprofen concentrations and target exposure over the first 3 days of treatment. Specifically, an ibuprofen concentration >20.5 mg/L at 8 hours after the first dose is associated with a 90% probability of reaching the target exposure.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

添加到收藏夹

Article Chemistry, Medicinal

Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)-ibuprofen

Roberto Padrini et al.

Summary: In neonates with patent ductus arteriosus, the half-life of S-IBU was found to be significantly longer than in adults, while the half-life of R-IBU was similar. The conversion rate from R to S-IBU was comparable to that in adults. Some patients exhibited higher S-IBU concentrations post-treatment, possibly due to rapid conversion and slow elimination rates.

CHIRALITY (2021)

添加到收藏夹

Review Health Care Sciences & Services

Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses

Samaher Al-Shaibi et al.

Summary: Ibuprofen is found to be equivalent or superior to indomethacin, and inferior or equivalent to paracetamol/acetaminophen in closing patent ductus arteriosus, with higher efficacy in oral form compared to IV form. Ibuprofen also has safety advantages over indomethacin, while indomethacin and paracetamol/acetaminophen are safer than IV ibuprofen. High dose of ibuprofen increases efficacy without increasing toxicity.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Fluid Intake in the First Week of Life and the Duration of Hemodynamically Significant Patent Ductus Arteriosus in Extremely Preterm Infants

Hussnain Mirza et al.

Summary: This study found that higher fluid intake in the first 2 days of life is associated with prolonged duration of hsPDA in extremely preterm infants. Actual daily fluid intake can be significantly higher than prescribed daily fluids due to daily weight changes and additional fluid administration.

AMERICAN JOURNAL OF PERINATOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus

Aline G. J. Engbers et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

添加到收藏夹

Article Pediatrics

Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenous

Thomas Bo Jensen et al.

Archives of Disease in Childhood-Fetal and Neonatal Edition (2019)

添加到收藏夹

Review Medicine, General & Internal

Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants A Systematic Review and Meta-analysis

Souvik Mitra et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns

Robert B. Flint et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)

添加到收藏夹

Article Pediatrics

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants

Bernard Barzilay et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2012)

添加到收藏夹

Article Pediatrics

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants

Omer Erdeve et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2012)

添加到收藏夹

Article Pediatrics

Efficacy and Safety of Oral Versus Intravenous Ibuprofen in Very Low Birth Weight Preterm Infants with Patent Ductus Arteriosus

Tulin Gokmen et al.

JOURNAL OF PEDIATRICS (2011)

添加到收藏夹

Article Toxicology

Ibuprofen: pharmacology, efficacy and safety

K. D. Rainsford

INFLAMMOPHARMACOLOGY (2009)

添加到收藏夹

Article Pharmacology & Pharmacy

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study

Deborah Hirt et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)

添加到收藏夹

Article Pharmacology & Pharmacy

Population Pharmacokinetic Analysis of Ibuprofen Enantiomers in Preterm Newborn Infants

Nicolas Gregoire et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2008)

添加到收藏夹

Article Pediatrics

Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus

Ahmed Cherif et al.

PEDIATRICS (2008)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics of oral ibuprofen in premature infants

PK Sharma et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.